Why Medicaid cuts could be a ‘crisis’ for people with disabilities
If the new administration slashes federal Medicaid spending, millions of people with disabilities would be cut off from critical health care services.
Related Articles
Investors call on UnitedHealth to disclose human and economic costs of policies that limit care
Health insurers like UnitedHealth are under tremendous public scrutiny for tactics such as prior authorization and care denials.
With a major patent cliff coming, will JPM play host to some serious deal-making?
The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P. Morgan Healthcare Conference.
Head trauma & herpes, antidepressants & breast milk, Califf & Humpty Dumpty
Research links head trauma, herpes and Alzheimer’s, and STAT has a Q&A with outgoing FDA chief Robert Califf.
Q&A: How electrical stimulation can improve rehabilitation after spinal cord injury
A new study found that high-frequency stimulation reduced spasticity, and improved patients’ ability to walk after spinal cord injury.
STAT@JPM: Health Care’s New Era
Join STAT’s biotech team in San Francisco as they take the stage to help you digest the biggest stories from the year’s JPM Healthcare Conference.
With a major patent cliff coming, will JPM play host to some serious deal-making?
The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P. Morgan Healthcare Conference.
STAT@JPM: Co-Working Space
Exclusive to STAT+ subscribers, STAT is hosting a workspace just steps from Union Square during the J.P. Morgan Healthcare Conference. Subsc…
Using lab-grown human mini-brains, scientists find links between head trauma, herpes, and Alzheimer’s
Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer’s.
Scribe Therapeutics becomes latest CRISPR company to announce layoffs
Scribe Therapeutics, co-founded by Jennifer Doudna, is reducing staff, the latest layoffs among companies focused on CRISPR therapies.
Scribe Therapeutics becomes latest CRISPR company to announce layoffs
Scribe Therapeutics, co-founded by Jennifer Doudna, is reducing staff, the latest layoffs among companies focused on CRISPR therapies.